These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32431090)

  • 1. Biodegradable
    Pang F; Li Y; Zhang W; Xia C; He Q; Li Z; Xiao L; Song S; Dong P; Zhou H; Shao T; Cai H; Li L
    Adv Healthc Mater; 2020 Jul; 9(13):e2000028. PubMed ID: 32431090
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Wu X; Ge L; Shen G; He Y; Xu Z; Li D; Mu C; Zhao L; Zhang W
    ACS Appl Mater Interfaces; 2022 May; 14(19):21848-21859. PubMed ID: 35507826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
    Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
    J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases.
    Kousik V; Promila P; Verma R; Gupta A
    Indian J Gastroenterol; 2016 May; 35(3):179-85. PubMed ID: 27185180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Imaging Biomarkers for
    Schobert I; Chapiro J; Nezami N; Hamm CA; Gebauer B; Lin M; Pollak J; Saperstein L; Schlachter T; Savic LJ
    J Nucl Med; 2019 Aug; 60(8):1066-1072. PubMed ID: 30655331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
    Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
    J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion.
    Reiner CS; Morsbach F; Sah BR; Puippe G; Schaefer N; Pfammatter T; Alkadhi H
    J Vasc Interv Radiol; 2014 May; 25(5):747-59. PubMed ID: 24630751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
    Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
    J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer composite microspheres loading
    Xiao L; Li Y; Geng R; Chen L; Yang P; Li M; Luo X; Yang Y; Li L; Cai H
    Biomater Res; 2023 Nov; 27(1):110. PubMed ID: 37925456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres.
    Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of Hepatocellular Carcinoma Response After
    Semaan S; Makkar J; Lewis S; Chatterji M; Kim E; Taouli B
    AJR Am J Roentgenol; 2017 Nov; 209(5):W263-W276. PubMed ID: 29072955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First
    De La Vega JC; Esquinas PL; Rodríguez-Rodríguez C; Bokharaei M; Moskalev I; Liu D; Saatchi K; Häfeli UO
    Theranostics; 2019; 9(3):868-883. PubMed ID: 30809314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma.
    Alem Z; Murray TE; Egri C; Chung J; Liu D; Elsayes KM; Chang SD; Harris A
    Abdom Radiol (NY); 2021 Aug; 46(8):3596-3614. PubMed ID: 33909092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
    Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
    J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioembolization with 90Y resin microspheres for HCC patients with extensive tumor thrombosis into the extrahepatic vessels.
    Ahmadzadehfar H; Pieper CC; Ezziddin S; Biersack HJ; Meyer C
    Clin Nucl Med; 2014 Mar; 39(3):305-7. PubMed ID: 24458185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.
    Herzer K; Müller S; Antoch G; Hilgard P
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):287-98. PubMed ID: 21769078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.
    Garin E; Rolland Y; Laffont S; Edeline J
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):559-75. PubMed ID: 26338177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET.
    Sabet A; Ahmadzadehfar H; Bruhman J; Sabet A; Meyer C; Wasmuth JC; Pieper CC; Biersack HJ; Ezziddin S
    Nuklearmedizin; 2014; 53(2):39-45. PubMed ID: 24777354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of therapy response to radioembolization with
    Ozkan E; Demir B; Oz DK; Soydal C; Dursun E; Celebioglu EC; Idilman R; Kucuk NO
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):316-317. PubMed ID: 37632564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.